Child, Only Clinical Trial
Official title:
Study on the Effect of Dietary Supplements on Height Improvement in Children
With the increasing improvement of living standard, more and more people are concerned about the body height of their children. It has been reported that 542 out of 1000 children (54.2%) failed to meet the standards of height. Moreover, nearly 80% was disappointed with the height of their children. The body height of child is mainly influenced by 60% of genetic factors (6 out of 10) and 40% of acquired factors which includes nutrition, exercise, sleep, psychology, disease and so on. Therefore, it is an important way to solve the problem by regulating the acquired factors. At present, inject growth hormone (GH) for children is the main way to solve the problem of children's body weight. However, high price, complex operation skills, and side effects limits the implication of GH. Additionally, the effect of traditional Chinese medicine therapy, exercise therapy, and dietary supplement are of dubious benefit and without clinical support. Elevated insulin like growth factor-1 (IGF-1) levels in the human body have been recognized as one of the core criteria for evaluating body enhancement therapy. Currently, there is no dietary supplement intervention to enhance the sensitivity of GH receptor and IGF-1 receptor. The goal of this clinical trial is to test the effect of dietary supplements on height improvement in children (aged 8-15 years of both genders). The main question it aims to answer is: Study the effect of dietary supplements (a formula based on enhancing the sensitivity of GH receptor and IGF-1 receptor) on height improvement in children by. Participants will be randomly divided into three groups: Placebo, Astragalus extract, and Wolfiporia extract. 1. Participants in the Placebo will consume placebo (a look-alike substances that contains no active drug) at a dose of 500 mg, twice a day (morning and evening) for 6 months. Participants in the Astragalus extract will take dietary supplement with astragalus extract at a dose of 450 mg, twice a day for the same duration. Participants in the Wolfiporia extract will take dietary supplement with wolfiporia extract at a dose of 15 g, twice a day for the same duration. 2. Taken blood sample at the timepoint of baseline (Day 0), intermediate point (Day 90), intervention end point (Day 180)) to detect biochemical markers, as well as body height and weight, and skeletal age. 3. Throughout the trial, subjects were asked to keep their usual lifestyle, food, and physical exercise and not took any dietary supplements. Researchers will compare the effects of Placebo with Astragalus extract, placebo with Wolfiporia extract, and Astragalus extract with Wolfiporia extract to see if Astragalus extract and Wolfiporia extract increase children's height, and whether Astragalus extract or Wolfiporia extract is more works well.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 20, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 8 Years to 15 Years |
Eligibility | Inclusion Criteria: 1. Body height: from the 10th to the 75th; 2. Skeletal age: bone age and actual age ±1. Exclusion Criteria: 1. Treated with growth hormone; 2. Sexual precocity; 3. Abnormal liver and kidney function; 4. IGF levels: below -2SD and above +2SD; 5. IGF BP3 level: below -2SD; 6. Growth hormone deficiency; 7. Diagnosed genetic disease; 8. BMI: Underweight or obese; 9. Abnormal thyroid function. |
Country | Name | City | State |
---|---|---|---|
China | College of Biosystems Engineering and Food Science | Hangzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Zhejiang University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline body height at 6 months | Determination of the change of body height of the participants at 6 months. | Baseline (Day 0), Intervention end point (Day 180) | |
Secondary | Change from baseline skeletal age at 6 months | Determination of the change of skeletal age of the participants at 6 months. | Baseline (Day 0), Intervention end point (Day 180) | |
Secondary | Change from baseline body weight at 6 months | Determination of the change of body weight of the participants at 6 months. | Baseline (Day 0), Intervention end point (Day 180) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06190457 -
Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma
|
||
Recruiting |
NCT04691349 -
CAR-T for r/r Malignant Tumors in Children
|
Early Phase 1 | |
Not yet recruiting |
NCT06455592 -
Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years
|
N/A | |
Not yet recruiting |
NCT05806983 -
Evaluation of the Efficiency of the Technology-Based Psychosocial Empowerment Program Program
|
N/A | |
Not yet recruiting |
NCT05566951 -
Technology-Based Psychosocial Empowerment Program for Home Care of Children With Cancer and Their Parents
|
N/A | |
Recruiting |
NCT05329467 -
Validation of Pain Assessment Scale Faces Thermometer Scale (FTS)
|
N/A | |
Not yet recruiting |
NCT04016506 -
Epidemiology, Management and Complications Related to Pancreatic Trauma in Children
|
||
Recruiting |
NCT05761847 -
Pediatric Medication Therapy Management Trial
|
N/A | |
Not yet recruiting |
NCT06291012 -
Stopping Pneumonia Antibiotherapy Regimen Early
|
Phase 4 | |
Not yet recruiting |
NCT05943587 -
The Development and Evaluation of Pain Neuroscience Education in Children
|
N/A | |
Recruiting |
NCT05109013 -
Juvenile Essential Arterial Hypertension and Vascular Function
|
||
Completed |
NCT04846400 -
Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia
|
N/A | |
Completed |
NCT04040036 -
Effects of Virtual Reality on Pain, Fear and Anxiety During Blood Draw in Children Aged 5-12 Years Old
|
N/A | |
Completed |
NCT03312881 -
Neuropathic Pain in Children: Multimodal Assessment and Diagnosis
|
||
Completed |
NCT04334733 -
The Impact of Preprocedural Animation About Echocardiography Display and Kaleidoscope Display on Anxiety in Children
|
N/A | |
Completed |
NCT06220383 -
Evaluation of The Effect of Crowns Applied With Hall Technique on Occlusion
|
N/A | |
Completed |
NCT03941392 -
Nutritional Study in Spanish Pediatric Population
|
||
Completed |
NCT03244332 -
HEMOCC Study. Hemostasis in Cirrhotic Children.
|
N/A | |
Not yet recruiting |
NCT06299267 -
The Effect of Dual Task on Manual Skill Performance in Children and Adolescents
|
N/A | |
Active, not recruiting |
NCT04070131 -
Horse Assisted Rehabilitation Postoncologic Treatment in Children and Adolescents: Physical and Psychological Effects
|
N/A |